Indolizinsulphones. A class of blockers with dual but discriminative effects on L-type Ca2+ channel activity and excitation-contraction coupling in skeletal muscle
- PMID: 1724076
- DOI: 10.1007/BF00370310
Indolizinsulphones. A class of blockers with dual but discriminative effects on L-type Ca2+ channel activity and excitation-contraction coupling in skeletal muscle
Abstract
The alpha 1 subunit of the L-type Ca2+ channel plays a dual role in skeletal muscle. It is essential both for L-type Ca2+ channel activity and for the functioning of the voltage-sensor structure that is situated in the triads as a key element for excitation-contraction coupling. This paper shows, with mouse muscle cells in primary culture, that indolizinsulphone SR33557 which has its binding site on the alpha 1 subunit blocks both L-type Ca2+ channel activity and contraction as the more classical 1,4-dihydropyridine blockers. However, unlike other Ca2+ channel blockers, it can pharmacologically discriminate between the two different roles of the alpha 1 subunit. SR33557 inhibition of both contractile and L-type Ca2+ channel activities is very voltage dependent and increases at depolarized potentials. Complete blockade of contraction was observed at low SR33557 concentrations (K0.5 = 20 nM) and was associated with only minor L-type Ca2+ channel blockade (30%). The remaining and major part of the L-type Ca2+ channel activity (70%) was blocked at much higher SR33557 concentrations (K0.5 = 0.6 microM). The results indicate that SR33557 has a much higher affinity for the alpha 1 subunit inserted into the voltage-sensor structure. They also suggest that the voltage-sensor structure, which probably includes most of the total T-tubule alpha 1 subunit, has intrinsic (but relatively small) Ca2+ channel activity.(ABSTRACT TRUNCATED AT 250 WORDS)
Similar articles
-
Effect of SR33557 on intramembrane charge movement in normal and 'muscular dysgenesis' mouse skeletal muscle cells.Eur J Neurosci. 1995 Jan 1;7(1):41-4. doi: 10.1111/j.1460-9568.1995.tb01018.x. Eur J Neurosci. 1995. PMID: 7711935
-
SR33557, an indolizinsulfone blocker of Ca2+ channels: identification of receptor sites and analysis of its mode of action.Mol Pharmacol. 1989 Jun;35(6):766-73. Mol Pharmacol. 1989. PMID: 2543910
-
Effects of two chemically related new Ca2+ channel antagonists, SR33557 (fantofarone) and SR33805, on the L-type cardiac channel.Eur J Pharmacol. 1994 Sep 22;263(1-2):101-5. doi: 10.1016/0014-2999(94)90529-0. Eur J Pharmacol. 1994. PMID: 7821341
-
Molecular basis of drug interaction with L-type Ca2+ channels.J Bioenerg Biomembr. 1998 Aug;30(4):319-34. doi: 10.1023/a:1021933504909. J Bioenerg Biomembr. 1998. PMID: 9758329 Review.
-
New drug binding sites in Ca2+ channels.Trends Pharmacol Sci. 1995 Apr;16(4):139-42. doi: 10.1016/s0165-6147(00)89002-1. Trends Pharmacol Sci. 1995. PMID: 7610500 Review.
Cited by
-
Inhibitory action of SR33557 on L-type calcium current in single ventricular myocytes of rat.Br J Pharmacol. 1995 Jan;114(2):468-74. doi: 10.1111/j.1476-5381.1995.tb13250.x. Br J Pharmacol. 1995. PMID: 7881746 Free PMC article.
-
Reduced Ca2+ current, charge movement, and absence of Ca2+ transients in skeletal muscle deficient in dihydropyridine receptor beta 1 subunit.Biophys J. 1996 Nov;71(5):2531-43. doi: 10.1016/S0006-3495(96)79446-8. Biophys J. 1996. PMID: 8913592 Free PMC article.
-
Coexistence of two classes of glibenclamide-inhibitable ATP-regulated K+ channels in avian skeletal muscle.Pflugers Arch. 1995 Nov;431(1):117-24. doi: 10.1007/BF00374384. Pflugers Arch. 1995. PMID: 8584408
-
Molecular pharmacology of high voltage-activated calcium channels.J Bioenerg Biomembr. 2003 Dec;35(6):491-505. doi: 10.1023/b:jobb.0000008022.50702.1a. J Bioenerg Biomembr. 2003. PMID: 15000518 Review.
-
Intramembrane charge movement in developing skeletal muscle cells from fetal mice.Pflugers Arch. 1992 Sep;421(6):572-7. doi: 10.1007/BF00375053. Pflugers Arch. 1992. PMID: 1437518
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Miscellaneous